Revelation Biosciences (REVB) Competitors $2.60 -0.03 (-1.14%) Closing price 04/1/2025 03:51 PM EasternExtended Trading$2.48 -0.12 (-4.77%) As of 04/1/2025 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock REVB vs. QNTM, PHXM, TRAW, APLM, PRPH, GELS, TXMD, KPRX, AIM, and INDPShould you be buying Revelation Biosciences stock or one of its competitors? The main competitors of Revelation Biosciences include Quantum Biopharma (QNTM), PHAXIAM Therapeutics (PHXM), Traws Pharma (TRAW), Apollomics (APLM), ProPhase Labs (PRPH), Gelteq (GELS), TherapeuticsMD (TXMD), Kiora Pharmaceuticals (KPRX), AIM ImmunoTech (AIM), and Indaptus Therapeutics (INDP). These companies are all part of the "pharmaceutical products" industry. Revelation Biosciences vs. Quantum Biopharma PHAXIAM Therapeutics Traws Pharma Apollomics ProPhase Labs Gelteq TherapeuticsMD Kiora Pharmaceuticals AIM ImmunoTech Indaptus Therapeutics Quantum Biopharma (NASDAQ:QNTM) and Revelation Biosciences (NASDAQ:REVB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, community ranking, analyst recommendations, institutional ownership and media sentiment. Does the media prefer QNTM or REVB? In the previous week, Quantum Biopharma had 10 more articles in the media than Revelation Biosciences. MarketBeat recorded 13 mentions for Quantum Biopharma and 3 mentions for Revelation Biosciences. Revelation Biosciences' average media sentiment score of 0.96 beat Quantum Biopharma's score of -0.12 indicating that Revelation Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quantum Biopharma 0 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Revelation Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings and valuation, QNTM or REVB? Quantum Biopharma is trading at a lower price-to-earnings ratio than Revelation Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuantum BiopharmaN/AN/A-$17.90M-$15.70-0.51Revelation BiosciencesN/AN/A-$120K-$139.86-0.02 Does the MarketBeat Community favor QNTM or REVB? Revelation Biosciences received 30 more outperform votes than Quantum Biopharma when rated by MarketBeat users. CompanyUnderperformOutperformQuantum BiopharmaN/AN/ARevelation BiosciencesOutperform Votes3063.83% Underperform Votes1736.17% Do insiders & institutionals have more ownership in QNTM or REVB? 1.2% of Quantum Biopharma shares are held by institutional investors. Comparatively, 12.8% of Revelation Biosciences shares are held by institutional investors. 8.5% of Quantum Biopharma shares are held by insiders. Comparatively, 0.1% of Revelation Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is QNTM or REVB more profitable? Quantum Biopharma's return on equity of -84.21% beat Revelation Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Quantum BiopharmaN/A -84.21% -62.63% Revelation Biosciences N/A -193.51%-84.00% Which has more risk and volatility, QNTM or REVB? Quantum Biopharma has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Comparatively, Revelation Biosciences has a beta of 0.17, indicating that its share price is 83% less volatile than the S&P 500. SummaryQuantum Biopharma beats Revelation Biosciences on 6 of the 11 factors compared between the two stocks. Remove Ads Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart REVB vs. The Competition Export to ExcelMetricRevelation BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.35M$6.75B$5.54B$7.86BDividend YieldN/A2.81%5.35%4.06%P/E Ratio-0.017.0923.4418.67Price / SalesN/A199.59367.8787.31Price / CashN/A65.6738.1634.64Price / Book0.015.966.634.09Net Income-$120,000.00$142.11M$3.20B$246.93M7 Day Performance-8.13%-7.60%-5.00%-3.16%1 Month Performance-25.50%-12.56%-1.57%-6.74%1 Year Performance-93.73%-13.53%8.72%-0.49% Revelation Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)REVBRevelation Biosciences1.6396 of 5 stars$2.60-1.1%N/A-93.9%$2.35MN/A-0.0110QNTMQuantum BiopharmaN/A$5.55-1.9%N/AN/A$10.65MN/A-0.36N/AEarnings ReportGap DownPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049TRAWTraws Pharma1.2093 of 5 stars$2.84flatN/AN/A$10.37M$226,000.00-0.0217Earnings ReportUpcoming EarningsGap UpAPLMApollomics2.5592 of 5 stars$9.50-4.0%$200.00+2,005.3%-89.8%$10.33M$1.22M0.0045Gap UpPRPHProPhase Labs1.7757 of 5 stars$0.43+39.0%N/A-94.1%$10.25M$12.75M-0.34130News CoverageGap UpGELSGelteqN/A$1.04-1.9%N/AN/A$10.00MN/A0.00N/ATXMDTherapeuticsMD0.8863 of 5 stars$0.87-2.8%N/A-57.8%$9.98M$1.60M0.00420Upcoming EarningsAnalyst ForecastShort Interest ↓KPRXKiora Pharmaceuticals3.1992 of 5 stars$3.23-1.8%$10.00+209.6%-45.7%$9.69M$16M0.0010Gap UpAIMAIM ImmunoTech1.8312 of 5 stars$0.14-1.1%$2.75+1,858.7%-74.5%$9.65M$190,000.00-0.3020INDPIndaptus Therapeutics3.4454 of 5 stars$0.66-8.4%$8.50+1,187.9%-78.1%$9.52MN/A-0.396High Trading Volume Remove Ads Related Companies and Tools Related Companies Quantum Biopharma Competitors PHAXIAM Therapeutics Competitors Traws Pharma Competitors Apollomics Competitors ProPhase Labs Competitors Gelteq Competitors TherapeuticsMD Competitors Kiora Pharmaceuticals Competitors AIM ImmunoTech Competitors Indaptus Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:REVB) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredOil Surge Predicted... But Are You Ready?Do you own oil and gas stocks? Or are you thinking about buying some? But it's NOT oil stocks, futures, or ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revelation Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
